Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma - Senzer, N N; Kaufman, H L; Amatruda, T (J Clin Oncol, 2009)